Impact of Health Education on Knowledge, Attitude and Practice of Post-exposure Prophylaxis

November 1, 2026 updated by: Fatma Ali Mahmoud Hussein, Aswan University

Impact of Health Education on Knowledge, Attitude and Practice of Post-exposure Prophylaxis Among Health Care Workers at Aswan University Hospital, Egypt

The goal of this study is to learn whether a short education programme helps healthcare workers know more about post-exposure prophylaxis (PEP). PEP is medicine taken soon after contact with blood or body fluids, to lower the chance of infection. The study takes place at Aswan University Hospital in Egypt.

The main questions it aims to answer are:

Do healthcare workers know more about PEP three months after the programme than before it?

Do their attitudes toward PEP change?

Do their reported actions change, such as hepatitis B vaccination, use of PEP after an exposure, and finishing the prescribed course?

Participants are doctors, nurses, and laboratory and blood bank staff who work with patients or blood samples. They will:

Fill out a questionnaire before the programme.

Attend four 2-hour teaching sessions over two weeks.

Fill out the same questionnaire about three months later.

All participants receive the programme. There is no comparison group. Researchers will compare each person's answers before and after the programme to see what changed.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Design. This is a single-group, before-and-after (quasi-experimental) study. Each participant completes a baseline questionnaire before teaching and a follow-up questionnaire about three months after their group finishes teaching. Coded identifiers link the two questionnaires. The study ran from 30 January 2026 to 30 June 2026.

Setting and participants. The study took place at Aswan University Hospital in southern Upper Egypt. Staff were selected by stratified random sampling from three groups: physicians and clinically active academic staff, nurses, and laboratory and blood bank staff. Workers had to be actively employed in one of these groups, have worked at the hospital for at least six months, and give written informed consent. Non-clinical, housekeeping and auxiliary staff were excluded. In total, 380 workers were selected, and the target was 340 with complete before-and-after data.

Intervention. The programme had four 2-hour sessions over two weeks. Topics were:

Recognising and reporting an exposure.

First aid.

Assessing the source patient and the exposure.

Access to PEP in the hospital.

Hepatitis B vaccination.

HIV PEP timing and duration.

Adherence, counselling and follow-up testing.

The programme also covered the difference between HIV prophylaxis, hepatitis B prevention and hepatitis C follow-up. Teaching used slides, short videos, case scenarios, group discussion and printed materials. Physicians were taught in English, and nurses and laboratory staff in Arabic.

Measures. A questionnaire, adapted from published PEP surveys and available in Arabic and English, was used at both time points.

Primary outcome: change in a five-item knowledge score (0-5), calculated as follow-up score minus baseline score.

Secondary outcomes: change in a seven-item attitude and belief score (0-7), and individual practice indicators. These are self-reported hepatitis B vaccination, PEP use after exposure, time to starting PEP, and completion of the prescribed course.

Analysis. Paired changes are tested with the Wilcoxon signed-rank test for scores and the exact McNemar test for yes/no responses. Confidence intervals are reported for paired differences. The sample size was calculated to estimate a proportion with 5% precision, not to detect a difference between paired groups.

Changes from the original registration. The original record described nine knowledge questions and threshold-based classifications of knowledge, attitude and practice. The final analysis uses a five-item knowledge score, a seven-item attitude total without an overall classification, and individual practice indicators. The dates were updated to the actual start (30 January 2026) and completion (30 June 2026).

Study Type

Interventional

Enrollment (Actual)

340

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Aswān, Egypt
        • Aswan faculty of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years to 55 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. HCWs at the selected departments (physicians, nurses and housekeepers).
  2. Age >18 years old and below 60 years old in both Genders.
  3. HCWs which have direct contact with blood and body fluids.

Exclusion Criteria:

  1. Age<18 years old and above 60 years old.
  2. Non-medical staff at Aswan university hospital.
  3. Health care workers which have no contact with blood or body fluids.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Health Care workers

About 340 participants of heath care workers undergoing assessment of knowledge, attitude and practice about post-exposure prophylaxis among health care workers at Aswan university hospital, Egypt Then they will undergo lecturers about about post-exposure prophylaxis, then reassessment will be done after 3 months

  1. Assess the baseline knowledge, attitudes and practices of health care workers at Aswan university hospital towards postexposure prophylaxis against blood-borne viral infection.
  2. Provide an intense post exposure prophylaxis health education sessions.
  3. Evaluate changes in post exposure prophylaxis knowledge, attitudes and practices after the health education intervention.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Health Practice Change
Time Frame: 3 Months

Assessment of participants after taking health education lecturers about post-exposure prophylaxis regrading to knowledge, attitude and practice and this done by questionnaire as :The questionnaire consisted of three sections assessing knowledge, attitude, and practice regarding post-exposure prophylaxis (PEP).

Section B assessed knowledge using nine close-ended questions, with adequate knowledge defined as ≥75% correct answers.

Section C included seven items evaluating attitudes toward the importance and effectiveness of PEP, with scores ≥75% indicating a good attitude.

Section D assessed PEP practices through nine questions, and good practice was defined as positive responses to more than 75% of items.

3 Months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Chair: Shaimaa Sayed Abdelrheem, M.D, Associate Professor of Public Health and Community Medicine, Faculty of medicine, Aswan University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 30, 2026

Primary Completion (Actual)

June 30, 2026

Study Completion (Actual)

June 30, 2026

Study Registration Dates

First Submitted

December 11, 2025

First Submitted That Met QC Criteria

January 4, 2026

First Posted (Actual)

January 9, 2026

Study Record Updates

Last Update Posted (Actual)

November 4, 2026

Last Update Submitted That Met QC Criteria

November 1, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • Post-exposure prophylaxis

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.